Experiment 69619
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Ginkgo biloba (GINKGOACEAE) |
| Citation | CIEZA,A: MAIER,P: POPPEL,E:. (2003). EFFECTS OF GINKGO BILOBA ON MENTAL FUNCTIONING IN HEALTHY VOLUNTEERS.. 34(5) |
| Amount utilized | |
| Compound isolated | |
| Disease | DRUG WERE FOUND FOR BOTH MOTOR PERFORMANCE AND EMOTIONAL EVALUATION. THIS STUDY DID NOT REVEAL EVIDENCE OF UNKNOW DRUG-INDUCED SIDE EFFECTS OR INTOLERANCE. NO SERIOUS ADVERSE EVENTS WERE OBSERVED DURING THE STUDY. MENTAL HEALTH AS WELL AS SELF-ESTIMATED QUALITY OF LIFE WERE SIGNIFICANT IN FAVOR OF EGB 761. NO INTERGROUP DIFFERENCES WERE FOUND IN SELF-ESTIMATED GENERAL HEALTH. SECONDARY OUTCOMES SUPPORTING THE NOTION OF SUPERIORITY OF THE ACTIVE STUDY WAS CONDUCTED. 66 HEALTHY VOLUNTEERS AGED BETWEEN 50 AND 65 YRS WITHOUT AGE-ASSOCIATED COGNITIVE IMPAIRMENT WERE RANDOMIZED, 32 INTO THE PLACEBO AND 34 INTO EGB 761-TREATMENT GROUP (240 MG, T.I.D.), INTERGROUP DIFFERENCES IN SELF-ESTIMATED THE OBJECTIVE OF THE PRESENT STUDY WAS TO EVALUATE THE RELATIVELY SHORT-TERM (I.E. 4 WKS) EFFECTS OF EGB 761 ON MENTAL FUNCTIONING AND QUALITY OF LIFE IN HEALTHY VOLUNTEERS. A 4-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP A COMMERCIAL PRODUCT, EGB-761, WAS USED. |
| Dose amount | 720.0 MG |
| Number | 2 |
| Qualitative result | INACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | ACETONE EXT |
| Gender | GIVEN TO BOTH SEXES |